These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38752508)

  • 1. APOE ε4 carrier status modifies plasma p-tau181 concentrations in cognitively healthy super-seniors.
    Cooper JG; Ghodsi M; Stukas S; Leach S; Brooks-Wilson A; Wellington CL
    Alzheimers Dement; 2024 Jun; 20(6):4373-4380. PubMed ID: 38752508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
    Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
    Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma phosphor-tau181 with Aβ levels may vary by APOE ε4 status and sex among non-demented old adults.
    Cai Y; Fu P; Zhang X;
    Neurosci Lett; 2023 Apr; 802():137161. PubMed ID: 36858305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's disease.
    Langella S; Bonta K; Chen Y; Su Y; Vasquez D; Aguillon D; Acosta-Baena N; Baena AY; Garcia-Ospina G; Giraldo-Chica M; Tirado V; Muñoz C; Ríos-Romenets S; Guzman-Martínez C; Pruzin JJ; Ghisays V; Arboleda-Velasquez JF; Kosik KS; Tariot PN; Reiman EM; Lopera F; Quiroz YT
    Alzheimers Res Ther; 2024 Oct; 16(1):208. PubMed ID: 39354618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in CSF biomarkers vary by Alzheimer disease stage and
    Babapour Mofrad R; Tijms BM; Scheltens P; Barkhof F; van der Flier WM; Sikkes SAM; Teunissen CE
    Neurology; 2020 Oct; 95(17):e2378-e2388. PubMed ID: 32788242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies.
    Twait EL; Kamarioti M; Verberk IMW; Teunissen CE; Nooyens ACJ; Monique Verschuren WM; Visser PJ; Huisman M; Kok AAL; Eline Slagboom P; Beekman M; Vojinovic D; Lakenberg N; Arfan Ikram M; Schuurmans IK; Wolters FJ; Moonen JEF; Gerritsen L; van der Flier WM; Geerlings MI;
    Am J Geriatr Psychiatry; 2024 Sep; 32(9):1141-1153. PubMed ID: 38553327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    Salami A; Adolfsson R; Andersson M; Blennow K; Lundquist A; Adolfsson AN; Schöll M; Zetterberg H; Nyberg L
    J Alzheimers Dis; 2022; 85(3):1309-1320. PubMed ID: 34924376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition.
    Weigand AJ; Ortiz G; Walker KS; Galasko DR; Bondi MW; Thomas KR;
    Neurobiol Aging; 2023 May; 125():1-8. PubMed ID: 36780762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults.
    Sible IJ; Nation DA;
    Neurology; 2022 Jun; 98(24):e2446-e2453. PubMed ID: 35418462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
    Nemes S; Logan PE; Manchella MK; Mundada NS; La Joie R; Polsinelli AJ; Hammers DB; Koeppe RA; Foroud TM; Nudelman KN; Eloyan A; Iaccarino L; Dorsant-Ardón V; Taurone A; Thangarajah M; Dage JL; Aisen P; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Womack KB; Wolk DA; Rabinovici GD; Carrillo MC; Dickerson BC; Apostolova LG;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S49-S63. PubMed ID: 37496307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
    Honig LS; Kang MS; Lee AJ; Reyes-Dumeyer D; Piriz A; Soriano B; Franco Y; Coronado ZD; Recio P; Mejía DR; Medrano M; Lantigua RA; Teich AF; Dage JL; Mayeux R
    JAMA Netw Open; 2023 Apr; 6(4):e238214. PubMed ID: 37079306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline.
    Lan G; Du J; Chen X; Wang Q; ; Han Y; Guo T
    Neurobiol Aging; 2023 Dec; 132():209-219. PubMed ID: 37852045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of
    Shang L; Dong L; Huang X; Wang T; Mao C; Li J; Wang J; Liu C; Gao J
    Front Aging Neurosci; 2023; 15():1119070. PubMed ID: 37065463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF Aβ
    Lim YY; Yassi N; Bransby L; Ayton S; Buckley RF; Eratne D; Velakoulis D; Li QX; Fowler C; Masters CL; Maruff P
    Neurobiol Aging; 2023 Sep; 129():209-218. PubMed ID: 37399739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic functional connectivity alterations in cognitively intact elderly APOE ε4 carriers measured by eigenvector centrality mapping are related to cognition and CSF biomarkers: a preliminary study.
    Luo X; Qiu T; Jia Y; Huang P; Xu X; Yu X; Shen Z; Jiaerken Y; Guan X; Zhou J; Zhang M;
    Brain Imaging Behav; 2017 Oct; 11(5):1290-1301. PubMed ID: 27714554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern.
    Risacher SL; Kim S; Nho K; Foroud T; Shen L; Petersen RC; Jack CR; Beckett LA; Aisen PS; Koeppe RA; Jagust WJ; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
    Alzheimers Dement; 2015 Dec; 11(12):1417-1429. PubMed ID: 25960448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.